VITASPRING BIOMEDICAL CO., LTD. Increase (Decrease) in Accounts Payable and Other Operating Liabilities
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$30.04 thousand for the 6-month period ending 2026-07-31, per its 10-Q filed 2026-09-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-09-17
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-07-31 was -$89.65K.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-04-30 was $59.61K, a 66.84% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-01-31 was $42.67K, a 12.55% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-10-31 was $165.49K, a 103.00% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for fiscal 2026 was $157.28K, a 0.98% increase from fiscal 2025.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was $155.75K, a 45.15% decline from fiscal 2024.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was $283.94K, a 75.93% decline from fiscal 2023.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was $1.18M.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-07-31 | -$89.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-17 | -$30.04K 10-Q · filed 2026-09-17 | $12.64K derived: sum of 3 quarters · filed 2026-09-17 | $178.13K derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2026-04-30 | $59.61K 10-Q · filed 2026-06-17 | $102.29K derived: sum of 2 quarters · filed 2026-06-17 | $267.77K derived: sum of 3 quarters · filed 2026-06-17 | $181.16K derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2026-01-31 | $42.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-17 | $208.16K derived: sum of 2 quarters · filed 2026-06-17 | $121.54K derived: sum of 3 quarters · filed 2026-09-17 | $157.28K 10-K · filed 2026-06-17 | ||
| 2025-10-31 | $165.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-17 | $78.87K derived: sum of 2 quarters · filed 2026-09-17 | $114.60K 10-Q · filed 2026-06-17 | $163.40K derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2025-07-31 | -$86.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-17 | -$50.88K 10-Q · filed 2026-09-17 | $64.74K 10-Q · filed 2026-06-17 | -$2.08K derived: sum of 3 quarters · filed 2026-09-17 | $79.43K derived: sum of 4 quarters · filed 2026-09-17 | |
| 2025-04-30 | $35.73K 10-Q · filed 2026-06-17 | $84.53K derived: sum of 2 quarters · filed 2026-06-17 | $166.05K derived: sum of 3 quarters · filed 2026-06-17 | $131.54K derived: sum of 4 quarters · filed 2026-06-17 | ||
| 2025-01-31 | $48.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-17 | $130.32K derived: sum of 2 quarters · filed 2026-06-17 | $95.81K derived: sum of 3 quarters · filed 2026-06-17 | $155.75K 10-K · filed 2026-06-17 | ||
| 2024-10-31 | $81.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-17 | $47.01K derived: sum of 2 quarters · filed 2026-06-17 | $106.95K 10-Q · filed 2026-06-17 | $129.44K derived: sum of 4 quarters · filed 2026-06-17 | ||
| 2024-07-31 | -$34.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-17 | $25.43K 10-Q · filed 2026-06-17 | $47.93K derived: sum of 3 quarters · filed 2026-06-17 | $157.98K derived: sum of 4 quarters · filed 2026-06-17 | ||
| 2024-04-30 | $59.95K 10-Q · filed 2026-06-15 | -$59.95K 10-Q · filed 2026-04-02 | $82.44K derived: sum of 2 quarters · filed 2026-06-15 | $192.49K derived: sum of 3 quarters · filed 2026-06-15 | $343.88K derived: sum of 4 quarters · filed 2026-06-15 | |
| 2024-01-31 | $22.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-08 | $132.55K derived: sum of 2 quarters · filed 2026-06-08 | $283.94K derived: sum of 3 quarters · filed 2026-06-08 | $283.94K 10-K · filed 2026-06-08 | ||
| 2023-10-31 | $110.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $261.44K derived: sum of 2 quarters · filed 2026-05-06 | $261.44K 10-Q · filed 2026-05-06 | |||
| 2023-07-31 | $151.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-22 | $151.39K 10-Q · filed 2026-04-22 | ||||
| 2023-04-30 | $0.00 10-Q · filed 2026-04-02 | |||||
| 2023-01-31 | $1.18M 10-K · filed 2026-03-12 |